Financial Performance - Total operating revenue for Q3 2025 was CNY 1,347,557,653, representing a year-on-year increase of 3.57%[7] - The total profit for the period was a loss of CNY 614,742,885, with a cumulative loss of CNY 2,117,139,906 year-to-date[7] - Net profit attributable to shareholders for Q3 2025 was a loss of CNY 588,342,675, with a cumulative loss of CNY 2,173,756,917 year-to-date[7] - Basic and diluted earnings per share for Q3 2025 were both CNY -0.18, with year-to-date figures at CNY -0.65[7] - The weighted average return on net assets was -7.52% for the reporting period and -25.24% year-to-date[7] - Total operating revenue for the first three quarters of 2025 was 4,366,877,339, compared to 4,730,946,624 in the same period of 2024, representing a decrease of approximately 7.7%[32] - Net profit for the first three quarters of 2025 was -2,330,960,103, compared to -1,052,709,814 in 2024, reflecting a deeper loss year-over-year[34] - Basic and diluted earnings per share for the first three quarters of 2025 were both -0.65, compared to -0.28 in the same period of 2024, indicating a worsening financial performance[37] - The total profit for the first three quarters of 2025 was 2,117,139,906, compared to -910,428,265 in 2024, showing a significant improvement in profit margins[34] Cash Flow - The net cash flow from operating activities for the year-to-date period was CNY 1,107,080,362, showing a significant increase of 114.45%[7] - Cash received from sales and services increased, contributing to the positive cash flow from operating activities[16] - Operating cash inflow for the first three quarters of 2025 reached RMB 5,456,892,004, a 12.4% increase from RMB 4,852,689,032 in the same period of 2024[38] - Cash outflow from operating activities totaled RMB 4,349,811,642 in 2025, slightly up from RMB 4,336,458,015 in 2024, resulting in a net cash flow from operating activities of RMB 1,107,080,362[39] - The company reported a negative net cash flow from operating activities of CNY -29,787,143 for the first three quarters of 2025[53] Assets and Liabilities - Total assets at the end of the reporting period were CNY 44,730,906,672, down 8.42% from the previous year-end[10] - Total current assets amounted to RMB 33.396 billion as of September 30, 2025, compared to RMB 37.039 billion as of December 31, 2024[26] - Total liabilities reached CNY 34,644,728,212 as of September 30, 2025, compared to CNY 37,074,445,175 as of December 31, 2024, representing a decline of approximately 6.56%[29] - Current liabilities totaled CNY 15,539,897,931 as of September 30, 2025, down from CNY 16,251,327,379 as of December 31, 2024, indicating a reduction of about 4.38%[28] - The total equity attributable to shareholders was CNY 7,525,340,978 as of September 30, 2025, down from CNY 9,699,142,595 as of December 31, 2024, a decrease of about 22.49%[30] - Total non-current assets amounted to CNY 11,335,101,571 as of September 30, 2025, compared to CNY 11,802,870,856 as of December 31, 2024, reflecting a decrease of approximately 3.96%[27] Revenue Segments - The company reported a significant decrease in revenue from the real estate development segment, impacting overall profitability[16] - The total operating revenue for the conference center and commercial properties reached RMB 429.71 million, with a total construction area of 367,900 square meters[22] - The hotel segment generated an operating revenue of RMB 556.05 million, with a total construction area of 346,800 square meters[22] - The office and comprehensive commercial segment achieved an operating revenue of RMB 507.93 million, with a total construction area of 578,500 square meters[22] - The apartment segment reported an operating revenue of RMB 198.86 million, with a total construction area of 184,300 square meters[22] Investment and Expenses - Research and development expenses for the first three quarters of 2025 were 2,989,412, while no R&D expenses were reported for the same period in 2024, indicating a strategic focus on innovation[32] - Other income for the first three quarters of 2025 was 26,613,703, down from 50,310,065 in 2024, reflecting a decline of approximately 47%[32] - Tax expenses for the first three quarters of 2025 were 213,820,197, compared to 142,281,549 in 2024, representing an increase of about 50%[34] - The company reported investment income of 31,467,979 for the first three quarters of 2025, compared to 32,907,914 in 2024, indicating a slight decrease[32] - The company experienced a net impairment loss of 72,907,152 in the first three quarters of 2025, compared to a loss of 143,168,208 in 2024, showing an improvement in asset management[34]

Financial Performance - The company's operating revenue for the third quarter was CNY 97,561,053, a decrease of 14.25% compared to the same period last year[9]. - The total profit for the quarter was CNY 1,742,502, reflecting a decline of 46.15% year-over-year[9]. - Net profit attributable to shareholders was CNY 870,881, down 67.52% from the previous year[9]. - The net profit after deducting non-recurring gains and losses was CNY 724,185, a decrease of 69.88% compared to the same period last year[9]. - The company reported a total profit for the year-to-date of CNY 7,021,651, down 21.26% compared to the same period last year[9]. - Net profit attributable to shareholders decreased by 41.88% due to continued decline in steel industry demand and external factors affecting the construction industry[13]. - Net profit attributable to shareholders, excluding non-recurring gains and losses, decreased by 45.74% year-to-date[13]. - Basic earnings per share for the quarter were CNY 0.04, down 69.23% year-over-year[9]. - Basic earnings per share decreased by 45.83% year-to-date, reflecting the impact of reduced profits[13]. - Total profit for the reporting period decreased by 46.15% compared to the same period last year[14]. - Net profit attributable to shareholders for the reporting period decreased by 67.52% year-on-year[14]. - Net profit attributable to shareholders, excluding non-recurring gains and losses, decreased by 69.88% for the reporting period[14]. - Basic earnings per share for the reporting period decreased by 69.23% year-on-year[14]. - Diluted earnings per share for the reporting period decreased by 69.23% year-on-year[14]. - Total operating revenue for the first three quarters of 2025 was RMB 335,093,765, a decrease of 18.8% compared to RMB 412,617,474 in the same period of 2024[31]. - Net profit for the first three quarters of 2025 was RMB 5,388,364, down 30.0% from RMB 7,699,234 in the first three quarters of 2024[32]. - Operating profit decreased to RMB 7,110,115 in 2025 from RMB 8,921,740 in 2024, reflecting a decline of 20.3%[32]. - Basic earnings per share for the first three quarters of 2025 were RMB 0.13, down from RMB 0.24 in 2024, a decrease of 45.8%[33]. - Total comprehensive income for the first three quarters of 2025 was RMB 5,254,846, compared to RMB 7,403,428 in 2024, reflecting a decline of 29.0%[33]. - The net profit for the first three quarters of 2025 was CNY 560,447,000, down from CNY 819,171,000 in the same period of 2024[50]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 873,007,755, an increase of 8.04% from the previous year[9]. - The company's total assets were RMB 873.01 billion, an increase from RMB 808.02 billion at the end of 2024[28]. - The company's current assets totaled RMB 656.90 billion, up from RMB 599.77 billion at the end of 2024[26]. - The company's total liabilities amounted to RMB 687.18 billion, compared to RMB 625.68 billion at the end of 2024[28]. - The company's total current assets increased to CNY 89,333,501,000 as of September 30, 2025, from CNY 82,687,765,000 at the end of 2024[43]. - The company's total liabilities increased to CNY 71,840,714,000 as of September 30, 2025, compared to CNY 64,022,791,000 at the end of 2024[44]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 282,523[16]. - The largest shareholder, China Minmetals Corporation, holds 44.26% of the shares[17]. - The company has a significant shareholder relationship, with China Minmetals Corporation and China Metallurgical Group Corporation acting in concert[20]. Cash Flow - The cash flow from operating activities was negative at CNY (19,391,096) for the year-to-date[9]. - Cash flow from operating activities showed a net outflow of RMB 19,391,096 in 2025, compared to a net outflow of RMB 30,735,612 in 2024, indicating an improvement[37]. - Cash inflow from investment activities totaled RMB 4,461,740 in 2025, significantly higher than RMB 1,143,924 in 2024[38]. - Cash flow from financing activities generated a net inflow of RMB 21,103,343 in 2025, compared to RMB 25,562,222 in 2024, showing a decrease of 17.5%[39]. - Cash and cash equivalents at the end of the first three quarters of 2025 amounted to $2,601,237, compared to $673,916 at the end of the same period in 2024[56]. - The company's cash and cash equivalents were RMB 51.53 billion, slightly down from RMB 52.56 billion at the end of 2024[26]. - The company's cash and cash equivalents at the end of September 2025 were CNY 43,617,771,000, compared to CNY 25,835,774,000 at the end of September 2024[40]. Contracts and New Business - The total new contracts signed by the company in the first three quarters of 2025 amounted to RMB 760.67 billion, a decrease of 14.7% compared to the same period last year[22]. - The new overseas contracts signed reached RMB 66.90 billion, representing a growth of 10.1% year-on-year[22]. Research and Development - Research and development expenses for the first three quarters of 2025 were RMB 9,961,687, down from RMB 11,900,695 in 2024, a reduction of 16.3%[31]. Operating Costs - The company reported a decrease in total operating costs to RMB 323,536,258 in 2025 from RMB 399,938,098 in 2024, a decline of 19.1%[31].

Financial Performance - Net profit attributable to shareholders for the first three quarters of 2025 was RMB 53.39 billion, a year-on-year increase of 3.02%[16] - Operating income for the first three quarters of 2025 was RMB 156.26 billion, a decrease of 3.43% compared to the same period last year[16] - The net interest margin was 1.63%, down 0.16 percentage points year-on-year, but improved by 0.02 percentage points quarter-on-quarter[16] - Non-interest income was RMB 48.56 billion, a decline of 6.34% year-on-year, with fee and commission income increasing by 5.75% to RMB 25.69 billion[16] - Operating expenses decreased by 4.23% year-on-year to RMB 46.45 billion, resulting in a cost-to-income ratio of 29.72%, down 0.25 percentage points year-on-year[16] - Interest income for the nine months ended September 30, 2025, was RMB 215,605 million, a decrease of 7.7% compared to RMB 233,709 million in the same period of 2024[67] - Net interest income for the same period was RMB 107,702 million, down 2.1% from RMB 109,971 million year-over-year[67] - The bank's net profit for the nine months ended September 30, 2025, was RMB 54,267 million, representing a 3.3% increase from RMB 52,531 million in the same period of 2024[68] - Basic earnings per share for the nine months ended September 30, 2025, was RMB 0.89, down from RMB 0.94 in the previous year[67] Asset and Liability Management - As of September 30, 2025, total assets reached RMB 9,898.13 billion, an increase of 3.83% compared to the end of 2024[8] - The total liabilities amounted to RMB 9,055.94 billion, an increase of 3.79% from the end of 2024[8] - The total equity attributable to shareholders was RMB 823.32 billion, reflecting a growth of 4.31% compared to the end of 2024[8] - The group's risk-weighted assets amounted to RMB 7,542,130 million, reflecting a 6.70% increase year-over-year[52] - The liquidity coverage ratio was reported at 127.60%, significantly lower than 218.13% at the end of the previous year[56] Loan and Deposit Growth - The total amount of loans and advances was RMB 5,782.48 billion, reflecting a growth of 1.09% from the end of 2024[8] - Customer deposits totaled RMB 6,067.33 billion, up 5.00% from the end of 2024[8] - The bank's general corporate loan balance reached RMB 2,974.28 billion, an increase of RMB 294.61 billion, or 10.99% year-on-year[17] - The long-term loans for the manufacturing sector grew by 15.44% to RMB 347.04 billion, while loans for strategic emerging industries and private economy increased by 13.14% to RMB 728.59 billion and 6.01% to RMB 1,428.28 billion, respectively[17] - The bank's personal loan balance (excluding credit cards) reached RMB 1,830.42 billion, an increase of RMB 15.01 billion compared to the end of the previous year[18] Digital and Technological Advancements - The bank's debit card quick payment transaction volume increased by 6.46% quarter-on-quarter in Q3 2025, while transaction amounts rose by 7.12%[21] - Credit card online transaction volume increased by 11.47% quarter-on-quarter in Q3 2025, with credit card loan balance reaching RMB 464.26 billion, an increase of RMB 5.80 billion from the end of Q2[21] - The bank's automated operations have improved review efficiency by 30%, enhancing overall operational effectiveness[28] - The bank's digital transformation strategy has led to an 18% reduction in average demand output time compared to the second quarter[35] Wealth Management and Investment - The bank's retail management asset balance (including market value) reached 5.26 trillion yuan, an increase of 12.12% compared to the end of the previous year[30] - The bank's wealth management business revenue grew by 13.59% year-on-year, with the total wealth management scale reaching CNY 326.574 billion, a 51.71% increase from the end of the previous year[38] - The number of wealth management clients increased to 10.92 million, a growth of 9.44% year-on-year[41] - The company created investment returns of CNY 33.71 billion for clients in the first nine months of 2025, a year-on-year increase of 15.15%[41] Risk Management and Capital Adequacy - The non-performing loan balance was CNY 66.94 billion, an increase of CNY 0.45 billion from the previous year-end, with a non-performing loan ratio of 1.16%[46] - The core tier one capital adequacy ratio was 9.59%, a decrease of 0.13 percentage points from the previous year-end[50] - The provision coverage ratio was 204.16%, a decrease of 5.27 percentage points from the previous year-end[47] - The capital adequacy ratio stood at 13.01%, down 0.35 percentage points from the previous year[52] Shareholder Information - The total number of ordinary shareholders reached 125,823, with A-share shareholders accounting for 101,048[57] - The largest shareholder, China CITIC Financial Holdings, holds 64.75% of the shares[58] - CITIC Financial Holdings Co., Ltd. holds a total of 36,610,129,412 shares, accounting for 65.79% of the total shares, including 33,264,829,933 A-shares and 3,345,299,479 H-shares[4]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因依 賴該等內容而引致之任何損失承擔任何責任。 Asymchem Laboratories (Tianjin) Co., Ltd. 凱萊英醫藥集團（天津）股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：6821） 二零二五年第三季度報告 本公告乃由凱萊英醫藥集團（天津）股份有限公司（「公司」或「本公司」，連同其附 屬公司統稱「本集團」）根據香港聯合交易所有限公司證券上市規則（「香港上市規 則」）第13.09條及第13.10B條以及證券及期貨條例（香港法例第571章）第XIVA部 項下的內幕消息條文（定義見香港上市規則）而作出。 茲載列本公司在深圳證券交易所網站刊發的《凱萊英醫藥集團（天津）股份有限公 司二零二五年第三季度報告》，僅供參閱。本公司二零二五年第三季度報告（「二 零二五年第三季度報告」）以中、英文雙語編製。如兩個版本有任何不相符之處， 應以中文版本為準。 本公司董事（「董事」）會（「董事會」）提醒本公司股東及潛在投資者 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因依賴該等內容而引致的任何損失承擔任何責任。 上海醫藥集團股份有限公司 Shanghai Pharmaceuticals Holding Co., Ltd. * （於中華人民共和國註冊成立的股份有限公司） （股份代碼：02607） 2025年第三季度報告 本公告乃根據證券及期貨條例（香港法例第571章）第XIVA部及香港聯合交易所有限公司 證券上市規則第13.09條而發表。 以下為上海醫藥集團股份有限公司2025年第三季度報告，其所載財務報告根據中國企業 會計準則編製，並且未經審計。 承董事會命 上海醫藥集團股份有限公司 楊秋華 董事長 中國上海，二零二五年十月三十一日 於本公告日期，本公司的執行董事為楊秋華先生、沈波先生、李永忠先生及董明先生； 非執行董事為張文學先生；以及獨立非執行董事為顧朝陽先生、霍文遜先生、王忠先生 及萬鈞女士。 * 僅供識別 - 1 - 本公司董事會及全體董事保證本公告內容不存在任何虛假記載、誤導性陳述或者重大遺 漏，並對 ...

Haier Smart Home Co., Ltd.* 海爾智家股份有限公司 （於中華人民共和國註冊成立之股份有限公司） 股份代號：6690 2025年第三季度報告 本公告乃海爾智家股份有限公司（「本公司」）根據香港法例第571章《證券及期貨條例》 第XIVA部項下內幕消息條文及香港聯合交易所有限公司證券上市規則第13.09(2)條及 第13.10B作出。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容 而產生或因依賴該等內容而引致的任何損失承擔任何責任。 – 2 – 一、主要財務數據 （一） 主要會計數據和財務指標 單位：元 幣種：人民幣 本公司於2025年第三季度之財務數據乃根據中國企業會計準則編製並未經審計。合併 財務報表所載歸屬於母公司所有者的淨利潤及歸屬於母公司所有者權益與該等根據國 際財務報告準則編製的財務資料並無差異。 – 1 – 重要內容提示： 公司董事會及董事、高級管理人員保證季度報告內容的真實、準確、完整，不存在虛假記載、誤 導性陳述或重大遺漏，並承擔個別和連帶的法律責任。 公司負責 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準 確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產 生或因倚賴該等內容而引致的任何損失承擔任何責任。 中國人壽保險股份有限公司 CHINA LIFE INSURANCE COMPANY LIMITED 炷㕤ᷕ厗Ṣ㮹ℙ⚳姣Ⅎㆸ䩳ᷳ偉ấ㚱旸℔⎠炸! 本公告由中國人壽保險股份有限公司（「本公司」）根據證券及期貨條例（香港法例第571章） 第XIVA部的內幕消息條文以及香港聯合交易所有限公司證券上市規則第13.09(2)條及第 13.10B條而作出。 重要內容提示 炷偉ấẋ嘇;!3739炸! 2025年第三季度報告 單位：人民幣百萬元 | | | | | 本報告期末 比上年度末 | | --- | --- | --- | --- | --- | | 項目 | 本報告期末 | | 上年度末 | 增減變動幅度 | | 資產總計 | 7,417,981 | | 6,769,546 | 9.6% | | 歸屬於母公司股東的股東 | 625,828 | | 509,675 | 22.8% | | 權益合計 | | | | ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示概不因本公告全部或任何部份內容而產 生或因依賴該等內容而引致的任何損失承擔任何責任。 截至二零二五年九月三十日止九个月期間 第三季度業績公告 上海復旦張江生物醫藥股份有限公司（「本公司」，聯同其附屬公司，「本集團」）之董 事會（「董事會」）欣然宣佈本集團截至二零二五年九月三十日止九個月期間按照中國企 業會計準則編製的未經審計財務資料。本公告乃根據香港法例第 571 章證券及期貨條例第 XIVA 部項下內幕消息條文及香港聯合交易所有限公司（「聯交所」）證券上市規則第 13.09(2) 和第 13.10B 條的要求作出。 主要財務數據 主要會計數據和財務指標 | | | | 單位：元 | 幣種：人民幣 | | --- | --- | --- | --- | --- | | | 截至二零二五年 | 比上年同期 | 截至二零二五年 | 比上年同期 | | 項目 | 九月三十日止 | 增減變動幅度 | 九月三十日止 | 增減變動幅度 | | | 三個月期間 | （%） | 九個月期間 | （%） | ...

Revenue and Profit - Revenue for the third quarter reached RMB 12,301,026,088.02, an increase of 24.88% compared to the same period last year[9] - Net profit attributable to shareholders was RMB 1,155,589,121.71, reflecting a growth of 35.80% year-over-year[9] - The net profit after deducting non-recurring gains and losses was RMB 718,347,769.07, a slight increase of 1.12% compared to the previous year[9] - Total revenue for the period reached RMB 37.16 billion, an increase of 8.2% compared to RMB 34.39 billion in the previous period[27] - Operating profit for the current period reached RMB 4,641,045,468.29, an increase of 20.6% from RMB 3,849,982,011.80 in the previous period[28] - Net profit attributable to shareholders of the parent company was RMB 3,920,367,724.61, up 25% from RMB 3,139,015,862.65 year-over-year[29] - Total comprehensive income for the current period amounted to RMB 4,115,715,418.49, compared to RMB 3,154,266,690.45 in the previous period, reflecting a growth of 30.5%[29] - Basic earnings per share increased to RMB 0.45 from RMB 0.38, representing a rise of 18.4%[29] Cash Flow - The cash flow from operating activities showed a significant increase of 137.31%, totaling RMB 2,866,113,330.72[9] - Cash flow from operating activities generated a net amount of RMB 2,866,113,330.72, significantly higher than RMB 1,207,754,698.86 in the previous period[31] - Cash inflow from investment activities totaled RMB 3,632,914,758.45, compared to RMB 2,653,293,585.32 in the previous period, marking a growth of 37%[33] - Cash outflow from investment activities was RMB 10,487,957,773.68, up from RMB 4,283,770,631.45, leading to a net cash flow from investment activities of -RMB 6,855,043,015.23[33] - Cash flow from financing activities showed a net increase of RMB 3,386,998,045.74, compared to a net decrease of RMB 505,061,294.18 in the previous period[33] - The total cash and cash equivalents at the end of the period were RMB 11,624,320,881.22, down from RMB 12,632,527,356.56 at the end of the previous period[34] - The impact of exchange rate changes on cash and cash equivalents was a positive RMB 70,832,665.22, compared to a negative impact of RMB 45,540,908.72 in the previous period[34] Assets and Liabilities - Total assets at the end of the reporting period amounted to RMB 131,105,845,143.43, representing a growth of 5.95% from the previous year[12] - The company's total assets reached RMB 131.11 billion, an increase of 5.4% from RMB 123.75 billion at the start of the period[24] - Total liabilities increased to RMB 70.54 billion, compared to RMB 63.91 billion at the start of the period, marking an increase of 10.3%[23] - Long-term borrowings rose significantly to RMB 20.80 billion, up 34.5% from RMB 15.41 billion at the beginning of the period[23] - Short-term borrowings surged to RMB 3.00 billion, a significant increase from RMB 1.43 billion at the beginning of the period, representing a rise of 109.0%[21] - Non-current assets totaled RMB 48.33 billion, down from RMB 49.32 billion at the beginning of the period, a decrease of 2%[19] - Deferred income tax assets decreased to RMB 2.50 billion from RMB 2.64 billion, a decline of 5.3%[19] Revenue Breakdown - Domestic revenue decreased by 5.38% to RMB 15,842,269,469.66, while overseas revenue increased by 20.80% to RMB 21,313,388,603.33[12] - The weighted average return on equity was 6.74%, an increase of 1.24% compared to the previous year[9] - The company reported a 121.16% increase in trading financial assets due to increased purchases of financial products[15] - Investment income surged by 4872.09% primarily from the sale of shares in joint ventures[15] Expenses - Total operating costs amounted to RMB 33.47 billion, up 7.3% from RMB 31.19 billion in the prior period[27] - Research and development expenses increased to RMB 2.05 billion, reflecting a rise of 10.1% from RMB 1.86 billion year-over-year[27]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部份內容而產生或 因倚賴該等內容而引致之任何損失承擔任何責任。 中國太平洋保險（集團）股份有限公司 CHINA PACIFIC INSURANCE (GROUP) CO., LTD. （於中華人民共和國註冊成立的股份有限公司） （股份代號：02601） 2025 年第三季度報告 本公告由中國太平洋保險（集團）股份有限公司（「本公司」）根據《證券及期貨條例》 第 XIVA 部及香港聯合交易所有限公司證券上市規則第 13.09 條及第 13.10B 條而作出。 本公司 2025 年第三季度報告所載財務資料根據中國企業會計準則編制，且未經審計。 §1 重要提示 1.1 本公司董事會、監事會及董事、監事、高級管理人員保證季度報告內容的真實、準確、 完整，不存在虛假記載、誤導性陳述或者重大遺漏，並承擔個別和連帶的法律責任。 1.2 本公司第十屆董事會第十八次會議於 2025 年 10 月 30 日審議通過了本公司《2025 年 第三季度報告》。應出席會議的董事 13 人，親自 ...